首页> 美国卫生研究院文献>Progress in Orthodontics >A prospective randomized clinical trial into the capacity of a toothpaste containing NovaMin to prevent white spot lesions and gingivitis during orthodontic treatment
【2h】

A prospective randomized clinical trial into the capacity of a toothpaste containing NovaMin to prevent white spot lesions and gingivitis during orthodontic treatment

机译:一项包含NovaMin的牙膏在正畸治疗期间预防白斑病变和牙龈炎的能力的前瞻性随机临床试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundWhite spot lesions and gingivitis represent common, yet challenging, dilemmas for orthodontists. Fluoride has shown some benefit as a protective measure against demineralization; however, this is usually insufficient for orthodontic patients with less than ideal oral hygiene. Dentifrices containing calcium sodium phosphosilicate bioactive glass (NovaMin) have been proposed to aid in prevention of white spot lesions and gingival inflammation. Thus, the purpose of this study was to determine if the use of NovaMin reduces the formation of white spot lesions and improves gingival health in orthodontic patients.
机译:背景白斑病变和牙龈炎是正畸医生的常见难题,但充满挑战。氟化物已显示出一些益处,可作为防止脱盐的保护措施;但是,这对于口腔卫生欠佳的正畸患者通常是不够的。已经提出了含有磷酸硅钙钙生物活性玻璃(NovaMin)的牙膏,以帮助预防白斑病变和牙龈发炎。因此,本研究的目的是确定NovaMin的使用是否能减少正畸患者的白斑病变并改善牙龈健康。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号